Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 OMKAR PHARMACHEM   TEVA PHARMA
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-23
TEVA PHARMA
Dec-13
OMKAR PHARMACHEM/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs253,479-   
Low Rs193,022-   
Sales per share (Unadj.) Rs0.51,996.4-  
Earnings per share (Unadj.) Rs0.2124.7-  
Cash flow per share (Unadj.) Rs0.2286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs9.02,217.6-  
Shares outstanding (eoy) m10.08848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x41.41.6 2,543.7%   
Avg P/E ratio x113.126.1 433.9%  
P/CF ratio (eoy) x111.511.4 981.7%  
Price / Book Value ratio x2.51.5 168.7%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m2242,756,220 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m10-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m51,692,969 0.0%  
Other income Rs m00-   
Total revenues Rs m51,692,969 0.0%   
Gross profit Rs m3463,620 0.0%  
Depreciation Rs m0136,844 0.0%   
Interest Rs m033,253 0.0%   
Profit before tax Rs m3293,523 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m1-3,584 -0.0%   
Profit after tax Rs m2105,758 0.0%  
Gross profit margin %57.627.4 210.3%  
Effective tax rate %25.2-1.2 -2,061.6%   
Net profit margin %36.66.2 586.4%  
BALANCE SHEET DATA
Current assets Rs m31,143,425 0.0%   
Current liabilities Rs m7997,163 0.0%   
Net working cap to sales %-78.58.6 -908.8%  
Current ratio x0.41.1 33.3%  
Inventory Days Days6,28691 6,923.7%  
Debtors Days Days87696 913.3%  
Net fixed assets Rs m93552,961 0.0%   
Share capital Rs m1014,167 2.4%   
"Free" reserves Rs m-100-   
Net worth Rs m901,880,567 0.0%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m963,868,976 0.0%  
Interest coverage x6.69.8 67.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.10.4 12.9%   
Return on assets %2.63.6 71.2%  
Return on equity %2.25.6 38.9%  
Return on capital %3.44.9 69.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m3269,772 0.0%  
From Investments Rs mNA-95,591 -0.0%  
From Financial Activity Rs m-4-323,609 0.0%  
Net Cashflow Rs m-1-149,429 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare OMKAR PHARMACHEM With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare OMKAR PHARMACHEM With: BROOKS LAB  ZOTA HEALTH CARE  SOTAC PHARMACEUTICALS LTD.  AARTI PHARMALABS  EARUM PHARMACEUTICALS  



Today's Market

HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.